Circulating microRNA as Biomarkers for Gestational Diabetes Mellitus—A Systematic Review and Meta-Analysis
International Journal of Molecular Sciences · 24.03.2023 · 24 (7) · 6186
DOI: 10.3390/ijms24076186 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.03.2023. Verfasst von Sofie Dinesen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science and Environment, Roskilde University, 4000 Roskilde, Denmark. Hauptthemen laut MEDLINE: Diabetes, Gestational, Circulating MicroRNA, Diabetes Mellitus, Type 2, MicroRNAs. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) is a severe pregnancy complication for both the woman and the child. Women who suffer from GDM have a greater risk of developing Type 2 diabetes mellitus (T2DM) later in life. Identification of any potential biomarkers for the early prediction of gestational diabetes can help prevent the disease in women with a high risk. Studies show microRNA (miRNA) as a potential biomarker for the early discovery of GDM, but there is a lack of clarity as to which miRNAs are consistently altered in GDM. This study aimed to perform a systematic review and meta-analysis to investigate miRNAs associated with GDM by comparing GDM cases with normoglycemic controls. The systematic review was performed according to PRISMA guidelines with searches in PubMed, Web of Science, and ScienceDirect. The primary search resulted in a total of 849 articles, which were screened according to the prior established inclusion and exclusion criteria. Following the screening of articles, the review was based on the inclusion of 35 full-text articles, which were evaluated for risk of bias and estimates of quality, after which data were extracted and relative values for miRNAs were calculated. A meta-analysis was performed for the miRNA species investigated in three or more studies: MiR-29a, miR-330, miR-134, miR-132, miR-16, miR-223, miR-155, miR-122, miR-17, miR-103, miR-125, miR-210, and miR-222. While some miRNAs showed considerable between-study variability, miR-29a, miR-330, miR-134, miR-16, miR-223, and miR-17 showed significant overall upregulation in GDM, while circulating levels of miR-132 and miR-155 were decreased among GDM patients, suggesting further studies of these as biomarkers for early GDM discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science and Environment, Roskilde University, 4000 Roskilde, Denmark.
- Roskilde Hospital, Region Zealand, 4000 Roskilde, Denmark.
ORCID-Profile: Sofie Dinesen, Anja Elaine Sørensen, Louise Torp Dalgaard
Zitieren
APA
Dinesen, S., El-Faitarouni, A., Frisk, N. L. S., Sørensen, A. E., & Dalgaard, L. T. (2023). Circulating microRNA as Biomarkers for Gestational Diabetes Mellitus—A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 24(7), 6186. https://doi.org/10.3390/ijms24076186
Vancouver
Dinesen S, El-Faitarouni A, Frisk NLS, Sørensen AE, Dalgaard LT. Circulating microRNA as Biomarkers for Gestational Diabetes Mellitus—A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2023;24(7):6186. doi:10.3390/ijms24076186
BibTeX
@article{Dinesen2023,
author = {Dinesen, Sofie and El-Faitarouni, Alisar and Frisk, Nanna Lond Skov and Sørensen, Anja Elaine and Dalgaard, Louise Torp},
title = {Circulating microRNA as Biomarkers for Gestational Diabetes Mellitus—A Systematic Review and Meta-Analysis},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6186},
doi = {10.3390/ijms24076186}
}
EUVIMED